RCM
RNC Capital Management Portfolio holdings
AUM
$2.06B
This Quarter Return
-2.55%
1 Year Return
+23.91%
3 Year Return
+56.62%
5 Year Return
+116.12%
10 Year Return
+214.42%
AUM
$1.35B
AUM Growth
+$1.35B
(-6.3%)
Cap. Flow
-$47.7M
Cap. Flow
% of AUM
-3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.65%
Holding
167
New
16
Increased
52
Reduced
66
Closed
12
Top Buys
| 1 |
Verizon
VZ
|
$20.6M |
| 2 |
AGN
Allergan plc
AGN
|
$6.21M |
| 3 |
Schlumberger
SLB
|
$5.72M |
| 4 |
Goldman Sachs
GS
|
$5.04M |
| 5 |
Comcast
CMCSA
|
$2.21M |
Top Sells
| 1 |
Blackrock
BLK
|
$34.9M |
| 2 |
DuPont de Nemours
DD
|
$20.3M |
| 3 |
Boeing
BA
|
$18M |
| 4 |
Apple
AAPL
|
$6.68M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
$4.14M |
Sector Composition
| 1 | Healthcare | 18.27% |
| 2 | Technology | 17.59% |
| 3 | Financials | 17.52% |
| 4 | Energy | 14.77% |
| 5 | Communication Services | 9.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$96B
| $54.5M | 4.03% |
861,978
+10,822
| +1% | +$684K |
|
|
2
Verizon
VZ
$186B
| $49.2M | 3.63% |
1,027,813
+431,790
| +72% | +$20.6M |
|
3
Microsoft
MSFT
$3.77T
| $49M | 3.62% |
536,416
+711
| +0.1% | +$64.9K |
|
4
JPMorgan Chase
JPM
$829B
| $48.8M | 3.61% |
444,016
+2,952
| +0.7% | +$325K |
|
5
TotalEnergies
TTE
$137B
| $48.1M | 3.55% |
833,898
-1,701
| -0.2% | -$98.1K |
|
6
Intel
INTC
$107B
| $44.8M | 3.31% |
860,662
+15,023
| +2% | +$782K |
|
7
AbbVie
ABBV
$372B
| $44.3M | 3.27% |
467,938
+752
| +0.2% | +$71.2K |
|
8
Wells Fargo
WFC
$263B
| $44.1M | 3.26% |
841,250
-16,631
| -2% | -$872K |
|
9
International Paper
IP
$26.2B
| $43.2M | 3.19% |
808,545
-10,270
| -1% | -$549K |
|
10
TSMC
TSM
$1.2T
| $43.1M | 3.18% |
985,095
-7,672
| -0.8% | -$336K |
|
11
Chevron
CVX
$324B
| $42.3M | 3.12% |
370,649
+4,176
| +1% | +$476K |
|
12
Cisco
CSCO
$274B
| $39.9M | 2.95% |
930,456
-196
| -0% | -$8.41K |
|
13
Altria Group
MO
$113B
| $38.2M | 2.82% |
612,682
+8,298
| +1% | +$517K |
|
14
Qualcomm
QCOM
$173B
| $37.7M | 2.79% |
680,496
+12,072
| +2% | +$669K |
|
15
Pfizer
PFE
$141B
| $37.1M | 2.74% |
1,045,187
-44,040
| -4% | -$1.56M |
|
16
MetLife
MET
$54.1B
| $36.9M | 2.72% |
803,222
+4,881
| +0.6% | +$224K |
|
17
AT&T
T
$209B
| $36.5M | 2.7% |
1,024,628
-46,911
| -4% | -$1.67M |
|
18
Travelers Companies
TRV
$61.1B
| $36.3M | 2.69% |
261,746
-1,349
| -0.5% | -$187K |
|
19
Eli Lilly
LLY
$657B
| $36.3M | 2.68% |
468,996
+3,561
| +0.8% | +$276K |
|
20
Phillips 66
PSX
$54B
| $35.3M | 2.61% |
367,989
-67
| -0% | -$6.43K |
|
|
21
Schlumberger
SLB
$55B
| $32.9M | 2.43% |
507,470
+88,283
| +21% | +$5.72M |
|
|
RDS.A
22
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $31M | 2.29% |
485,787
+13,295
| +3% | +$848K |
|
23
Amgen
AMGN
$155B
| $30.5M | 2.26% |
179,188
+3,564
| +2% | +$608K |
|
24
Johnson & Johnson
JNJ
$427B
| $29.1M | 2.15% |
226,951
+567
| +0.3% | +$72.7K |
|
25
Omnicom Group
OMC
$15.2B
| $29M | 2.14% |
399,304
+18,688
| +5% | +$1.36M |
|